The website of the Clinical Services Journal

Ground-breaking regional anaesthesia system to become available in Saudi Arabia, the UAE and Bahrain

UK-based Medovate has announced an agreement with AKSIA Healthcare FZC to distribute its SAFIRA (SAFer Injection for Regional Anaesthesia) product range in Saudi Arabia, the UAE and Bahrain.

SAFIRA is a Class II medical device system which is transforming regional anaesthesia around the world by making it a one-person procedure and incorporating a built-in safety system to automatically limit injection pressure. Following regulatory approvals, SAFIRA will become available through AKSIA Healthcare FZC in these three key Middle East markets.  

Developed in collaboration with clinicians from the National Health Service (NHS) in the UK, the award-winning system puts full control of the injection in the hands of the anaesthetist, freeing up the previously required assistant to carry out other tasks. The system also helps to improve patient safety by reducing the risk of nerve damage as it automatically limits injection pressure to less than 20psi.   

Speaking about their partnership with AKSIA Healthcare FZC Chris Rogers, sales and marketing director, at Medovate, said: “We are delighted to be working with Aksia Healthcare FZC as we now work towards launching SAFIRA in these key markets. This agreement will allow patients and clinicians in both governmental and private facilities to benefit from the value that SAFIRA brings to safer regional anaesthesia.”

Ahmed Sallam, managing director of AKSIA Healthcare FZC, added: “We are pleased to enter this partnership with Medovate to distribute SAFIRA across the United Arab Emirates, Saudi Arabia and Bahrain. There is a real need for a system like this, not only to help improve patient safety but also to have a huge impact on the way regional anesthesia is carried out.”

SAFIRA was demonstrated live at Arab Health 2022 by one of its inventors, Dr. Emad Fawzy, a consultant anaesthetist, at the flagship Sheikh Khalifa Medical City in Abu Dhabi.  

Dr. Fawzy added: “I am delighted that this pioneering UK-developed medical system will soon be available to use across more Middle East states. The system has already been used by clinicians across the world and feedback has been overwhelmingly positive. We are expecting a large demand for it from Middle Eastern clinicians as it has a huge impact on patient safety.”

SAFIRA has the potential to make a significant impact by making injection during regional anaesthesia safer, reducing the risk of nerve injury from injection at high pressures. It won the United Kingdom HSJ ‘Patient Safety Innovation of the Year’ award in 2021.

Upcoming Events

Infection 360: What's trending in infection prevention & control

Edgbaston Stadium, Birmingham
27-28 September 2022

IP2022 IS COMING TO BOURNEMOUTH IN OCTOBER 2022

Bournemouth
17-19 October 2022

UKHCA Conference: Listen Up

Pendulum Hotel and Manchester Conference Centre, Manchester
3rd November 2022

MEDICA 2022

Dusseldorf Germany
14th November - 17th November

Future Surgery 2022

ExCel, London
15th - 16th November 2022

IDSc Annual Conference

The Eastside Rooms, Birmingham
29th - 30th November 2022

Access the latest issue of Clinical Services Journal on your mobile device together with an archive of back issues.

Download the FREE Clinical Services Journal app from your device's App store

Upcoming Events

Infection 360: What's trending in infection prevention & control

Edgbaston Stadium, Birmingham
27-28 September 2022

IP2022 IS COMING TO BOURNEMOUTH IN OCTOBER 2022

Bournemouth
17-19 October 2022

UKHCA Conference: Listen Up

Pendulum Hotel and Manchester Conference Centre, Manchester
3rd November 2022

MEDICA 2022

Dusseldorf Germany
14th November - 17th November

Future Surgery 2022

ExCel, London
15th - 16th November 2022

IDSc Annual Conference

The Eastside Rooms, Birmingham
29th - 30th November 2022

Access the latest issue of Clinical Services Journal on your mobile device together with an archive of back issues.

Download the FREE Clinical Services Journal app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2022 Step Communications Ltd. Registered in England. Registration Number 3893025